FDA Inspection 1271100 — Petar Bilic, MD, PhD

Petar Bilic, MD, PhD — FEI 3033552895

The FDA completed an inspection of Petar Bilic, MD, PhD on Mar 21, 2025 in Zagreb. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Mar 21, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Zagreb (Croatia)

Additional details

Clinical BA/BE

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.